
Ann D. Rhoads
Director · QuidelOrtho Corp
- 2025
- Jun 29, 2026
- 13
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ann D. Rhoads files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephen T. Zarrilli - $4.28M in GMED purchases and sales in the last 12 months
- David D. Davidar - $4.17M in GMED purchases and sales in the last 12 months
- Kelly Huller - $3.44M in GMED purchases and sales in the last 12 months
- James R. Tobin - $2.24M in GMED purchases and sales in the last 12 months
- Kyle Kline - $2.03M in GMED purchases and sales in the last 12 months
- Brian J. Blaser - $750K in QDEL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ann D. Rhoads?
Ann D. Rhoads is a corporate insider, tracked as Director of QuidelOrtho Corp (QDEL). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Ann D. Rhoads last file a Form 4?
The most recent primary Form 4 on record is dated 29 June 2026, one of 13 filings going back to 2025.
Has Ann D. Rhoads been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($1.40M) across all tracked filings.